Literature DB >> 28966998

Calcium Transient Assays for Compound Screening with Human iPSC-derived Cardiomyocytes: Evaluating New Tools.

Neil J Daily1, Radleigh Santos2, Joseph Vecchi1, Pinar Kemanli1, Tetsuro Wakatsuki1.   

Abstract

Calcium (Ca2+) plays a central role in regulating many biological processes in the cell from muscle contraction to neurotransmitter release. The need for reliable fluorescent calcium indicator dyes is of vast importance for studying many aspects of cell biology as well as screening compounds using phenotypic high throughput assays. We have assessed two of the latest generation of calcium indicator dyes, FLIPR Calcium 6 and Cal-520 AM for studying calcium transients (CaTs) in induced pluripotent stem cell (iPSC) -derived human cardiomyocytes. FLIPR Calcium 6 and Cal-520 dyes both displayed robust CaTs with a high signal-to-noise ratio (SNR) and were non-toxic to the cells. The analysis showed that CaT amplitudes were stable between measurements, but CaT duration was more variable and tended to increase between reads. Two methods were compared for drug-screening hit-selection; difference in average (unstandardized) and standardized difference. The unstandardized difference was better for assessing CaT amplitude, whereas standardized difference was equal to or better for assessing CaT duration. In summary, FLIPR Calcium 6 and Cal-520 are suitable dyes for drug-screening using iPSC-derived human cardiomyocytes.

Entities:  

Year:  2017        PMID: 28966998      PMCID: PMC5621642          DOI: 10.14302/issn.2574-4372.jesr-16-1395

Source DB:  PubMed          Journal:  J Evol Stem Cell Res


  18 in total

Review 1.  Cardiac excitation-contraction coupling.

Authors:  Donald M Bers
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  Modulation of potassium channels by antiarrhythmic and antihypertensive drugs.

Authors:  M C Sanguinetti
Journal:  Hypertension       Date:  1992-03       Impact factor: 10.190

Review 3.  Mathematical models in decision analysis.

Authors:  E Tom; K A Schulman
Journal:  Infect Control Hosp Epidemiol       Date:  1997-01       Impact factor: 3.254

4.  Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Haoyu Zeng; Maria I Roman; Edward Lis; Armando Lagrutta; Frederick Sannajust
Journal:  J Pharmacol Toxicol Methods       Date:  2016-05-21       Impact factor: 1.950

Review 5.  Evolution of strategies to improve preclinical cardiac safety testing.

Authors:  Gary Gintant; Philip T Sager; Norman Stockbridge
Journal:  Nat Rev Drug Discov       Date:  2016-02-19       Impact factor: 84.694

6.  Ratiometric Ca²+ measurements using the FlexStation® Scanning Fluorometer.

Authors:  Ian C B Marshall; Izzy Boyfield; Shaun McNulty
Journal:  Methods Mol Biol       Date:  2005

7.  Utility of hERG assays as surrogate markers of delayed cardiac repolarization and QT safety.

Authors:  Gary A Gintant; Zhi Su; Ruth L Martin; Bryan F Cox
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

8.  Evaluation of FLIPR Calcium 3 Assay Kit--a new no-wash fluorescence calcium indicator reagent.

Authors:  Yingxin Zhang; Dianne Kowal; Angela Kramer; John Dunlop
Journal:  J Biomol Screen       Date:  2003-10

Review 9.  Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Claire Robertson; David D Tran; Steven C George
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

10.  Evaluation of no-wash calcium assay kits: enabling tools for calcium mobilization.

Authors:  Hong Xin; Yuanping Wang; Matthew J Todd; Jianshen Qi; Lisa K Minor
Journal:  J Biomol Screen       Date:  2007-05-30
View more
  6 in total

1.  Assessing Drug-Induced Long QT and Proarrhythmic Risk Using Human Stem-Cell-Derived Cardiomyocytes in a Ca2+ Imaging Assay: Evaluation of 28 CiPA Compounds at Three Test Sites.

Authors:  Hua Rong Lu; Haoyu Zeng; Ralf Kettenhofen; Liang Guo; Ivan Kopljar; Karel van Ammel; Fetene Tekle; Ard Teisman; Jin Zhai; Holly Clouse; Jennifer Pierson; Michael Furniss; Armando Lagrutta; Frederick Sannajust; David J Gallacher
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

Review 2.  Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?

Authors:  Arne An Bruyneel; Wesley L McKeithan; Dries Am Feyen; Mark Mercola
Journal:  Curr Opin Pharmacol       Date:  2018-08-03       Impact factor: 5.547

3.  SMN-deficiency disrupts SERCA2 expression and intracellular Ca2+ signaling in cardiomyocytes from SMA mice and patient-derived iPSCs.

Authors:  Guzal Khayrullina; Kasey E Moritz; James F Schooley; Naheed Fatima; Coralie Viollet; Nikki M McCormack; Jeremy T Smyth; Martin L Doughty; Clifton L Dalgard; Thomas P Flagg; Barrington G Burnett
Journal:  Skelet Muscle       Date:  2020-05-08       Impact factor: 4.912

4.  Ultra-high-throughput Ca2+ assay in platelets to distinguish ITAM-linked and G-protein-coupled receptor activation.

Authors:  Delia I Fernández; Isabella Provenzale; Hilaire Y F Cheung; Jan van Groningen; Bibian M E Tullemans; Alicia Veninga; Joanne L Dunster; Saman Honarnejad; Helma van den Hurk; Marijke J E Kuijpers; Johan W M Heemskerk
Journal:  iScience       Date:  2021-12-31

5.  Uninterrupted monitoring of drug effects in human-induced pluripotent stem cell-derived cardiomyocytes with bioluminescence Ca2+ microscopy.

Authors:  Kazushi Suzuki; Takahito Onishi; Chieko Nakada; Shunsuke Takei; Matthew J Daniels; Masahiro Nakano; Tomoki Matsuda; Takeharu Nagai
Journal:  BMC Res Notes       Date:  2018-05-18

Review 6.  Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug Discovery.

Authors:  Michael J Greenberg; Neil J Daily; Ann Wang; Michael K Conway; Tetsuro Wakatsuki
Journal:  Front Cardiovasc Med       Date:  2018-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.